Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related BAX
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical
My 4% Dividend Yield Portfolio: Or Is It 5% Now? (Seeking Alpha)
Related CVC
Cablevision Q2 Profit Tops Views
Earnings Scheduled For August 7, 2015
Telecom Stock Roundup: FCC Reveals Plan for Incentive Auction, DISH-Sinclair to Ink New Content Carriage Deal (Zacks)

Analysts at Mizuho downgraded Baxter International (NYSE: BAX) from “buy” to “neutral.” Baxter's shares closed at $66.84 yesterday. Baxter's trailing-twelve-month profit margin is 16.36%.

Analysts at Canaccord downgraded Cablevision Systems (NYSE: CVC) from “buy” to “hold.” Cablevision's shares closed at $14.02 yesterday. Cablevision's trailing-twelve-month ROA is 9.77%.

Analysts at RBC Capital downgraded McMoRan Exploration Co (NYSE: MMR) from “outperform” to “sector perform.” McMoRan Exploration's shares closed at $9.65 yesterday. McMoRan Exploration's PEG ratio is -4.48.

Bernstein downgraded Boston Scientific (NYSE: BSX) from “outperform” to “market perform.” Boston Scientific's shares closed at $5.66 yesterday. Boston Scientific's trailing-twelve-month ROE is -43.84%.

Latest Ratings for BAX

DateFirmActionFromTo
Aug 2015BarclaysMaintainsOverweight
Aug 2015Credit SuisseAssumesNeutral
Jul 2015Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for BAX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BAX + BSX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters